You searched for "PDR"
Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system
24 July 2024
|
Research & Development
Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...
Royal College of Surgeons of Edinburgh recruiting new board members and trainee representative for SSBs
21 February 2023
The Surgical Specialty Boards (SSBs) are constituted within the internal governance structure of the College and exist primarily to support, advise and assist the College and its Council across the breadth of core College activities as they relate to specialty...
Clinical Specialist opportunity to join the team at Surgitrac Instruments
6 October 2023
|
Recruitment & Personnel
A super opportunity is offered for an experienced and motivated Clinical Specialist with Surgitrac Instruments.
Neuro-ophthalmic disease patterns in Southeast Asia with particular reference to giant cell arteritis
1 April 2016
| James F (Barry) Cullen, Lakana Kumar Thavaratnam
|
EYE - Neuro-ophthalmology
As indicated in an earlier article in Eye News [1] Dr Cullen was invited in 2000 to the Singapore National Eye Centre (SNEC) as visiting Professor with a specific remit to set up a specialist neuro-ophthalmology service, which was the...
Intravitreal afibercept and ranibizumab for PCV
1 August 2016
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...
Management of giant retinal tears with vitrectomy and perfluorocarbon liquid postoperatively as a short-term tamponade
1 April 2018
| Saruban Pasu
|
EYE - Vitreo-Retinal
The authors report an eight year retrospective case series study of 30 eyes of 29 patients with who underwent a giant retinal tear-related retinal detachment repair. M: F ratio was 23:6. Right to left eye ratio was 16:14. The mean...
Stereotactic radiotherapy for polypoidal choroidal vasculopathy
1 August 2015
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Polypoidal choroidal vasculopathy (PCV) is a variant of neovascular AMD. It is a disease of choroidal vasculature characterised by abnormal branching vascular network with aneurysmal dilatations (polyps). Features of PCV include pigment epithelial detachments (PED), subretinal fluid (SRF) accumulation and...
OCTA use in CNV associated with CSR
1 June 2018
| Saruban Pasu
|
EYE - Vitreo-Retinal
The aim of this study was to assess the rate of choroidal neovascularisation (CNV) in chronic central serous chorioretinopathy (CSR) patients with flat irregular pigment epithelial detachments (PEDs) by optical coherence tomography angiography (OCTA). Data of all consecutive patients with...
RPE tears in cases of IPCV
1 April 2020
| Saruban Pasu
|
EYE - Vitreo-Retinal
The aim of this study was to investigate the occurrence, characteristics, management and prognosis of retinal pigment epithelium (RPE) tears in patients with polypoidal choroidal vasculopathy (PCV). Medical records of previous cases were reviewed over an eight-year period from a...
Air tamponade in pars plana vitrectomy for primary rhegmatogenous retinal detachment repair
1 June 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Air tamponade, Multiple retinal tears, Pars plana vitrectomy, Retinal detachment surgery
The authors report a study aimed to establish the use of air as a tamponade agent for primary rhegmatogenous retinal detachment (RRD) treatment, regardless of the position or the number of retinal breaks. Two hundred and thirty-six eyes of 230...
Innovation update: key advances in eyecare transformation in the last year
1 December 2021
| Vishal Shah, Alexander Chiu, Guy Mole, Melanie Hingorani
|
EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
Vishal Shah and his co-authors reflect on examples of innovation in eyecare delivery published in the last year and the implications for the future of eyecare services. The “new normal” is an overused phrase to describe extraordinary measures that have...